Search

Your search keyword '"Simonneau G"' showing total 1,347 results

Search Constraints

Start Over You searched for: Author "Simonneau G" Remove constraint Author: "Simonneau G" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,347 results on '"Simonneau G"'

Search Results

4. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

8. External Validation of a Refined 4 Strata Risk Assessment Score from the French Pulmonary Hypertension Registry

9. Доклад ERS по хронической тромбоэмболической легочной гипертензии

10. ERS statement on chronic thromboembolic pulmonary hypertension

11. Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy

12. Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis

20. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

21. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

22. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

23. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

24. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

25. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

28. Switching to Riociguat from Phosphodiesterase-5 Inhibitors, With or Without Endothelin Receptor Antagonists, in Patients with Pulmonary Arterial Hypertension: Results from the REPLACE Study

29. BPA and Riociguat for the Management of Inoperable CTEPH: Results of the Extension Study Following the RACE Randomized Controlled Trial (RCT)

30. Screening for Pulmonary Arterial Hypertension in Adults Carrying a BMPR2 Mutation

32. Analysis of Risk Assessment Tools in the REPLACE Study

34. Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities

40. Trithérapie initiale dans l’hypertension artérielle pulmonaire

41. Pulmonary hypertension in orphan lung diseases

48. Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study

49. Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of the Randomized Controlled TRITON Study

Catalog

Books, media, physical & digital resources